Back to top
more

Cantel Medical Corp. (CMD)

(Delayed Data from NYSE)

$68.92 USD

68.92
263,823

+0.38 (0.55%)

Updated May 3, 2019 04:02 PM ET

After-Market: $68.94 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

OPKO Health's (OPK) BioReference Extends Digital Health Access

by Zacks Equity Research

OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.

Cantel Medical (CMD) is a Great Momentum Stock: Should You Buy?

by Zacks Equity Research

Does Cantel Medical (CMD) have what it takes to be a top stock pick for momentum investors? Let's find out.

STERIS (STE) to Expand Product Suite Via Cantel Medical Buyout

by Zacks Equity Research

STERIS (STE) expects to strengthen and expand its endoscopy offerings along with extending into a new customer territory via the Cantel Medical buyout.

Neuronetics (STIM) in Focus: Stock Moves 6.8% Higher

by Zacks Equity Research

Neuronetics (STIM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

PerkinElmer (PKI) to Buy Oxford Immunotec for $591 million

by Zacks Equity Research

PerkinElmer's (PKI) acquisition of Oxford Immunotec will expand its portfolio of advanced infectious disease testing solutions.

Conformis (CFMS) Looks Good: Stock Adds 7.7% in Session

by Zacks Equity Research

Conformis (CFMS) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

Accuray (ARAY) Gets 510(k) Nod for ClearRT in TomoTherapy

by Zacks Equity Research

Accuray (ARAY) new innovative imaging solution is designed to provide cost effective and exceptional diagnostic quality image.

Integra (IART) to Buy ACell, Expand Regenerative Capability

by Zacks Equity Research

Integra (IART) expects to close the ACell acquisition in the first quarter of 2021, subject to fulfilment of closing conditions.

Top Ranked Momentum Stocks to Buy for December 23rd

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 23rd.

Is Cantel (CMD) a Solid Growth Stock? 3 Reasons to Think " Yes "

by Zacks Equity Research

Cantel (CMD) possesses solid growth attributes, which could help it handily outperform the market.

Cantel (CMD) Upgraded to Strong Buy: Here's What You Should Know

by Zacks Equity Research

Cantel (CMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Top Ranked Momentum Stocks to Buy for December 21st

by Zacks Equity Research

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 21st.

New Strong Buy Stocks for December 21st

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.

Company News for Dec 9, 2020

by Zacks Equity Research

Companies In The News Are: SFIX,HRB,CMD,MRNA

Cantel Medical (CMD) Q1 Earnings and Revenues Top Estimates

by Zacks Equity Research

Cantel (CMD) delivered earnings and revenue surprises of 150.00% and 1.55%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Cantel Medical (CMD) Q1 Earnings Expected to Decline

by Zacks Equity Research

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Cantel (CMD) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Cantel (CMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

New Strong Sell Stocks for October 12th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

New Strong Sell Stocks for October 8th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

The Truth About Market Timing - October 06, 2020

by Zacks Equity Research

In the long-run, does consistent market timing really matter to be a successful investor?

New Strong Sell Stocks for October 1st

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

New Strong Sell Stocks for August 28th

by Zacks Equity Research

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

Cantel Medical (CMD) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Cantel (CMD) delivered earnings and revenue surprises of 200.00% and 0.14%, respectively, for the quarter ended July 2020. Do the numbers hold clues to what lies ahead for the stock?

The Keys to Successfully Timing the Markets - September 15, 2020

by Zacks Equity Research

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

Earnings Preview: Cantel Medical (CMD) Q4 Earnings Expected to Decline

by Zacks Equity Research

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.